Search

Myun Ki Han

from Ellicott City, MD
Deceased
Get Report
Also known as:
Myun K Han, Man Suk Han, Man S Han, Albert M Han, Ki Myun Han, Man S Kim, Myun Kihan, Man Suk Kim, Suk Kim Man, Han Myun Ki
Phone and address:
11722 Foxspur Ct, Ellicott, MD 21042
(443) 535-0029
Related to:
Shungven L Han, 50Kim Won, 75Jung S Kim, 74Hun Kim, 46Chris Kim, 82
Connected to:
Ace F Han, 55Aiguo Han, 68Andy C Han, 70Arin Han, 45Bo N Han, 32Casey L Han, 35Chieh W Han, 58Chuang Han, 105Edgar Han, 42Eunae A Han, 55

Myun Han Phones & Addresses

  • 11722 Foxspur Ct, Ellicott City, MD 21042 (443) 535-0029
  • Baltimore, MD
  • 12121 Early Lilacs Path, Clarksville, MD 21029 (443) 535-0029
  • Lawndale, CA
  • 2742 Sweet Clover Ct, Silver Spring, MD 20904 (301) 572-7568
  • Wilmington, DE
  • Bethesda, MD
  • Los Angeles, CA

Work

Position: Professional Specialty Occupations

Education

Degree: Graduate or professional degree

Resumes

Resumes

Myun Han Photo 1

President & Ceo At Excimus Biotech

View page
Position:
President & CEO at Excimus Biotech
Location:
Baltimore, Maryland Area
Industry:
Biotechnology
Work:
Excimus Biotech since Mar 2001
President & CEO
Education:
The Johns Hopkins University 1983 - 1988
Doctor of Philosophy (Ph.D.), Biochemisry and Biophysics
Myun Han Photo 2

Managing Director

View page
Location:
8510 Corridor Rd, Savage, MD 20763
Industry:
Non-Profit Organization Management
Work:
Korea-Us Science Corporation Center Feb 2017 - Apr 2018
Executive Director
Korea Innovation Center Feb 2017 - Apr 2018
Director General
Kusco Apr 2016 - Feb 2017
Chairmen of Finance Committee
Excimus Biotech Mar 2001 - 2016
President and Chief Executive Officer
Joen Enterprise Mar 2001 - 2016
Managing Director
Education:
The Johns Hopkins University 1983 - 1988
Doctorates, Doctor of Philosophy, Biochemistry, Biophysics, Philosophy Uc San Diego 1982
Bachelors, Bachelor of Arts, Biochemistry, Biology
Myun Han Photo 3

Chief Executive Officer

View page
Location:
Ellicott City, MD
Industry:
Hospital & Health Care
Work:
Excimus Biotech
Chief Executive Officer
Myun Han Photo 4

Chairman Of Finance Committee

View page
Location:
Baltimore, MD
Work:
Kusco
Chairman of Finance Committee
Myun Han Photo 5

Myun Han

View page

Business Records

Name / Title
Company / Classification
Phones & Addresses
Myun K. Han
Owner
Joen Enterprises, Inc
Business Services
12121 Early Lilacs Path, Clarksville, MD 21029
11722 Foxspur Ct, Ellicott, MD 21042

Publications

Us Patents

Fluorometric Assay For Detecting Nucleic Acid Cleavage

View page
US Patent:
6787304, Sep 7, 2004
Filed:
Apr 30, 1998
Appl. No.:
09/069847
Inventors:
Myun Ki Han - Silver Spring MD
S. Paul Lee - Phoenix MD
Jack Chirikjian - Potomac MD
Assignee:
Georgetown University - Washington DC
International Classification:
C12Q 168
US Classification:
435 6, 435 911, 435 912, 435 915, 536 231, 536 243, 536 2431, 536 2432, 536 2433
Abstract:
A method of detecting an enzyme-mediated DNA cleavage reaction in a fluorometric assay is provided. The method can be used to detect DNA cleavage caused by restriction endonucleases, retroviral integrase enzymes, DNases, RNases, or enzymes utilized in other strand separating processes in molecular biology.

Fluorometric Assay For Detecting Nucleic Acid Cleavage

View page
US Patent:
7112422, Sep 26, 2006
Filed:
Apr 29, 2003
Appl. No.:
10/424796
Inventors:
Myun Ki Han - Silver Spring MD, US
S. Paul Lee - Phoenix MD, US
Jack G. Chirikjian - Potomac MD, US
Assignee:
Georgetown University - Washington DC
International Classification:
C12P 19/34
C12Q 1/68
C07H 21/02
US Classification:
435 911, 435 6, 435 912, 536 231
Abstract:
A method of detecting an enzyme-mediated DNA cleavage reaction in a fluorometric assay is provided. The method can be used to detect DNA cleavage caused by restriction endonucleases, retroviral integrase enzymes, DNases, RNases, or enzymes utilized in other strand separating processes in molecular biology.

Fluorometric Assay For Detecting Nucleic Acid Cleavage

View page
US Patent:
20030165908, Sep 4, 2003
Filed:
Jul 10, 2002
Appl. No.:
10/191964
Inventors:
Myun Han - Silver Spring MD, US
S. Lee - Phoenix MD, US
Jack Chirikjian - Potomac MD, US
Assignee:
Georgetown University
International Classification:
C12Q001/68
C12P019/34
US Classification:
435/006000, 435/091200
Abstract:
A method of detecting an enzyme-mediated DNA cleavage reaction in a fluorometric assay is provided. The method can be used to detect DNA cleavage caused by restriction endonucleases, retroviral integrase enzymes, DNases, RNases, or enzymes utilized in other strand separating processes in molecular biology.

Real-Time Detection Of Nucleic Acids And Proteins

View page
US Patent:
20050214809, Sep 29, 2005
Filed:
Nov 24, 2004
Appl. No.:
10/997674
Inventors:
Myun Han - Clarksville MD, US
International Classification:
C12Q001/68
US Classification:
435006000
Abstract:
The present invention provides a method for real-time detection of an independent target nucleic acid or target nucleic acid linked to a secondary structure through signal amplification (direct detection) or through detection of the target nucleic acid sequence which has been the subject of an amplification process. A probe including a detectable marker is hybridized to either an independent target nucleic acid or a linked target nucleic acid to provide verification of the presence of the target nucleic acid and/or secondary structure to which the target nucleic acid is linked within either isothermal or non-isothermal environments of homogeneous or heterogeneous systems.

Compounds Obtained From Salvia Species Having Antiviral Activity

View page
US Patent:
60432764, Mar 28, 2000
Filed:
Jun 25, 1999
Appl. No.:
9/339813
Inventors:
Myun K. Han - Silver Spring MD
Paul Lee - Phoenix MD
Assignee:
Georgetown University School of Medicine - Washington DC
International Classification:
A01N 3710
A61K 31765
US Classification:
514532
Abstract:
Compositions are provided containing molecules having at least one moiety from. beta. -(3,4-dihydroxyphenyl) lactic acid and/or caffeic acid, which are found in extracts from the plant genus Salvia, said moieties being of the formula: ##STR1## the active agents having a molecular weight of at least 190 daltons. A class of preferred agents are those which are conjugated to form dimers, trimers, tetramers and larger polymers containing said moieties, with the most preferred being salvianolic acid dimers, trimers, tetramers and larger polymers. The compounds and compositions may be administered in pharmaceutically acceptable carriers and excipients systemically or locally to treat viral infections.

Compounds Obtained From Salvia Species Having Antiviral Activity

View page
US Patent:
60373695, Mar 14, 2000
Filed:
Jun 25, 1998
Appl. No.:
9/104363
Inventors:
Myun K. Han - Silver Spring MD
Paul Lee - Phoenix MD
Assignee:
Georgetown University School of Medicine - Washington DC
International Classification:
A01N 6500
A61K 39385
A61K 3578
US Classification:
514532
Abstract:
The instant invention provides compositions containing molecules having at least one moiety from. beta. (3,4-dihydroxyphenyl) lactic acid and/or caffeic acid which are found in extracts from genus Salvia, said moieties being of the formula: ##STR1## said active agents having a molecular weight of at least 190 daltons. A class of preferred agents are those which are conjugated to form dimers and larger polymers containing said moieties. The agents of the invention may be administered in pharmaceutically acceptable carriers systemically or locally.

Extracts Of Salvia Species Having Antiviral Activity

View page
US Patent:
59944005, Nov 30, 1999
Filed:
Dec 4, 1997
Appl. No.:
8/985105
Inventors:
Myun K. Han - Silver Spring MD
Paul Lee - Phoenix MD
Assignee:
Georgetown University School of Medicine - Washington DC
International Classification:
A01N 6500
A61K 3578
A61K 39385
US Classification:
514532
Abstract:
This invention provides extracts of Salvia species essentially consisting of that fraction from a Salvia that precipitates from aqueous solution at pH. ltoreq. 3, said precipitate having the property such that it is is essentially fully dissolved in aqueous solution at pH 6, with solubility beginning to be readily observable at about pH 4, said extract having a molecular weight of. ltoreq. 3500 datons. A preferred embodiment of the invention provides active agents having a molecular weight of. ltoreq. 1000 daltons.

Extracts Of Salvia Species Having Antiviral Activity

View page
US Patent:
61179035, Sep 12, 2000
Filed:
Aug 19, 1999
Appl. No.:
9/377038
Inventors:
Myun K. Han - Silver Spring MD
Paul Lee - Phoenix MD
Assignee:
Georgetown University - Washington DC
International Classification:
A01N 6500
A01N 3710
US Classification:
514533
Abstract:
This invention provides extracts of Salvia species essentially consisting of that fraction from a Salvia that precipitates from aqueous solution at pH. ltoreq. 3, said precipitate having the property such that it is is essentially fully dissolved in aqueous solution at pH 6, with solubility beginning to be readily observable at about pH 4, said extract having a molecular weight of. ltoreq. 3500 datons. A preferred embodiment of the invention provides active agents having a molecular weight of. ltoreq. 1000 daltons.
Control profile
Myun Ki Han from Ellicott City, MDDeceased Get Report